Home
Scholarly Works
MODELLED IMPACT OF NIRSEVIMAB FOR ALL INFANTS IN...
Conference

MODELLED IMPACT OF NIRSEVIMAB FOR ALL INFANTS IN PREVENTING RESPIRATORY SYNCYTIAL VIRUS (RSV): RELATED HOSPITALIZATIONS AND COSTS IN THE BRAZILIAN PRIVATE HEALTHCARE SYSTEM

Authors

Falavigna M; Watanabe SF; Santoro J; Ribeiro K; Schneider N; Safadi M; Stein RT; Kieffer A; Tolardo A

Volume

26

Pagination

pp. S33-S33

Publisher

ELSEVIER SCIENCE INC

Publication Date

December 1, 2023

Conference proceedings

VALUE IN HEALTH

Issue

12

ISSN

1098-3015

Contact the Experts team